BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

IMRIS Release: Zhengzhou Neurosurgeons Perform First iMRI Case in VISIUS® Surgical Theatre


2/7/2013 10:35:21 AM

Brings cutting edge surgery and precise tumor operation platform to patient care

WINNIPEG, Feb. 7, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that neurosurgeons at the First Affiliated Hospital of Zhengzhou University in Zhengzhou City, China, have successfully performed the first case involving an adult male brain tumor patient using the recently installed VISIUS® Surgical Theatre.

Allowing for multiple MR scanning during brain tumor operations without compromising patient safety, the VISIUS Surgical Theatre features a high-field MR scanner that travels on demand using ceiling-mounted rails into a state-of-the-art neurosurgical operating room. As in this initial case, serial scanning gives the surgeon the ability to assess and perform further resection to remove as much tumor as possible.

With integrated technologies and control systems for imaging, patient-handling and information management, the VISIUS Surgical Theatre provides unmatched intraoperative vision to surgeons to assist in their surgical decision-making and enhance treatment precision. When not needed for intraoperative imaging, the scanner remains in a diagnostic room where it can be used for inpatient and outpatient imaging.

Zhengzhou University Hospital is the third IMRIS system installed in China. Other locations are: PLA General Hospital in Beijing and Huashan Hospital at Fudan University in Shanghai. Two other VISIUS Surgical Theatres are currently being installed at Peking Union Medical College Hospital in Beijing and First Affiliated Hospital of Jilin University in Changchun.

The day before the first procedure, Dr. Xianzhi Liu, chief neurosurgeon, reviewed the surgical suite with province health department representatives. "Since we are the biggest and leading hospital in Henan province," he said, "we have a responsibility to our patients to utilize cutting edge technology that brings the most precise surgical capabilities."

When the hospital announced purchase of the VISIUS Surgical Theatre in March 2012, Kan Quancheng, hospital president, said the suite "is the essential, leading-edge technology that will take us to the next level of research and clinical practice, especially in neurosurgery."

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.


SOURCE IMRIS Inc.


Read at BioSpace.com

IMRIS
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->